Drug
Met DR
Met DR is a pharmaceutical drug with 5 clinical trials. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 5 completed trials
Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
100%(5 trials)
Phase Distribution
Ph phase_1
2
40%
Ph phase_2
3
60%
Phase Distribution
2
Early Stage
3
Mid Stage
0
Late Stage
Phase Distribution5 total trials
Phase 1Safety & dosage
2(40.0%)
Phase 2Efficacy & side effects
3(60.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
5 of 5 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
5
all time
Status Distribution
Completed(5)
Detailed Status
Completed5
Development Timeline
Analytics
Development Status
Total Trials
5
Active
0
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 12 (40.0%)
Phase 23 (60.0%)
Trials by Status
completed5100%
Recent Activity
0 active trials
Showing 5 of 5
completedphase_2
Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM
NCT02526524
completedphase_2
Assessing the Efficacy, Safety, and Tolerability of Met DR in Subjects With T2DM Over 12 Weeks
NCT01819272
completedphase_1
Assessing the PK of Met DR, Met IR, and Met XR in Healthy Subjects
NCT02291510
completedphase_1
Assessing the Effect of Met DR on Plasma Glucose and PK in Subjects With T2DM
NCT01804842
completedphase_2
Assessing the Behavior of Met DR in Subjects With Kidney Dysfunction
NCT01658514
Clinical Trials (5)
Showing 5 of 5 trials
NCT02526524Phase 2
Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM
NCT01819272Phase 2
Assessing the Efficacy, Safety, and Tolerability of Met DR in Subjects With T2DM Over 12 Weeks
NCT02291510Phase 1
Assessing the PK of Met DR, Met IR, and Met XR in Healthy Subjects
NCT01804842Phase 1
Assessing the Effect of Met DR on Plasma Glucose and PK in Subjects With T2DM
NCT01658514Phase 2
Assessing the Behavior of Met DR in Subjects With Kidney Dysfunction
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5